Scope of the Study
Renal denervation is a minimally invasive endovascular catheter-based procedure to treat resistant hypertension. Renal denervation treatment is used for hypertension and chronic kidney disease. It uses radiofrequency waves to disrupt the overactive sympathetic nerves running along the arteries in the kidneys. The factors such as Increased Prevalence of Hypertension and Kidney Diseases among People, Increased Number of Diagnostic Centres and Hospitals and Changing Lifestyle of the People are the driving factors for the global renal denervation treatment market.
The market study is being classified, by Application (Hospitals, Ambulatory Surgical Centers and Others) and major geographies with country level break-up.
St. Jude Medical (United States), ReCor Medical, Inc. (United States), Boston Scientific (United States), Medtronic (Ireland), Kona Medical, Inc. (United States), Mercator MedSystems, Inc. (United States), Terumo Corporation (Japan), Abbott Laboratories (United States), Theragenics Corporation (United States) and Hansen Medical, Inc. (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Biosense Webster Inc (United States) and Ablative Solutions, Inc. (United States).
The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain competitive advantage through combined collaborations.
AdvanceMarketAnalytics has segmented the market of Global Renal Denervation Treatment market by Type, Application and Region.
On the basis of geography, the market of Renal Denervation Treatment has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increased Prevalence of Hypertension and Kidney Diseases among People
- Increased Number of Diagnostic Centres and Hospitals
- Changing Lifestyle of the People
- Growth in the Healthcare Infrastructure in Developing Countries
- Cost-Effectiveness of the Procedure
- Risks Associated with the Procedure
- Less Awareness among People About Treatment
- Growing in the Healthcare Industry Worldwide
- Increased Research and Development Activities
- Stringent Government Rules and Regulations
In November 2019, Terumo Corporation has announced that it has decided to acquire Aortica Corporation, a United States based company dedicated to advancing the science of personalized vascular therapy.
Key Target AudienceRenal Denervation Treatment Providers, Emerging Companies, Research Professionals and End-users
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase